Related Experiment Videos

Cardiac function in pediatric septic shock survivors

Hendrika Knoester1, Jeanine J Sol, Pascal Ramsodit

  • 1Pediatric Intensive Care Unit, Emma Children's Hospital, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. h.knoester@amc.uva.nl

Insights

Most pediatric septic shock survivors show excellent cardiac recovery. However, some experience rhythm disturbances and reduced ventricular function, necessitating long-term cardiac monitoring for these children.

Area of Science:

  • Pediatric critical care medicine
  • Cardiology
  • Septic shock research

Background:

  • Septic shock is a life-threatening condition in children.
  • Long-term effects of pediatric septic shock on cardiac function are not fully understood.
  • Inotropic and vasoconstrictive agents are commonly used in treating pediatric septic shock.

Purpose of the Study:

  • To evaluate the long-term cardiac effects in children who survived septic shock.
  • To assess cardiac function in pediatric septic shock survivors treated with specific medications for extended periods.
  • To identify potential cardiac abnormalities in pediatric septic shock survivors.

Main Methods:

  • Cohort study design.
  • Involved 108 pediatric septic shock survivors and 52 healthy controls.
  • Assessed cardiac function through history, physical exam, ECG (rest, exercise, 24-hour Holter), and ventricular function tests.

Main Results:

  • Most survivors had normal cardiac function and no symptoms.
  • 6% of survivors exhibited cardiac abnormalities.
  • Abnormalities included premature ventricular contractions and decreased left/right ventricular function.

Conclusions:

  • Pediatric septic shock survivors generally exhibit good cardiac recovery.
  • A subset of survivors may develop long-term cardiac issues like arrhythmias and ventricular dysfunction.
  • Long-term cardiac follow-up is recommended for pediatric septic shock survivors, especially considering aging effects.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...